| ²é¿´: 1216 | »Ø¸´: 3 | |||||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||||||
[½»Á÷]
Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿ÔºRalf×éÕÐÆ¸ÖúÀíÑо¿Ô±/Ñо¿ÊµÏ°Ô±
|
|||||||
Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿ÔºRalf×éÕÐÆ¸ÖúÀíÑо¿Ô±/Ñо¿ÊµÏ°Ô±£¬Ò©Îïµ°°×·½Ïò£¬Ñо¿×é×鳤ѧÊõˮƽºÍΪÈ˶¼²»´í£¬Óкܶà¹ú¼ÊºÏ×÷»ï°é£¬¹¤×÷ÓïÑÔΪӢÓï¡£ÒÔÏÂΪÕÐÆ¸ÐÅÏ¢£º Call for a Research Associate in Protein-Drug Interaction Unit I am seeking to recruit a highly motivatedResearch Associate with a relevant University degree to join an internationalteam at the Guangzhou Institutes of for Biomedicine and Health (GIBH), ChineseAcademy of Sciences. The job will involve molecular biologytechniques, the recombinant production, purification and characterization ofproteins for drug discovery projects. A theoretical background and hands-onexperience in biochemical and biophysical techniques (SPR, ITC, EMSA, MST, CD,FP, FRET) to study protein-protein, protein-DNA and protein-drug interactionsare highly desirable. A background in x-ray crystallography and computationalstructural biology would be a plus. A good command of both English and Chinese ismandatory as work is done international team. We seek self-motivated andambitious colleagues with a strong drive for high level accomplishments, anindependent and critical approach to research and who integrate smoothly into ourteam. Please consult the below link for further information: http://english.gibh.cas.cn/drug/groups/ralf/ Interested candidates please send yourresume to: ralf@gibh.ac.cn |
» ²ÂÄãϲ»¶
354Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
»¯Ñ§¹¤³Ì321·ÖÇóµ÷¼Á
ÒѾÓÐ22È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ3È˻ظ´
326Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
333Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸¶«»ª´óѧ¿ØÖÆÑ§Ë¶320Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
¿¼Ñл¯Ñ§Ñ§Ë¶µ÷¼Á£¬Ò»Ö¾Ô¸985
ÒѾÓÐ7È˻ظ´
0703»¯Ñ§µ÷¼Á
ÒѾÓÐ15È˻ظ´
0703»¯Ñ§µ÷¼Á £¬Áù¼¶Òѹý£¬ÓпÆÑоÀú
ÒѾÓÐ14È˻ظ´
326Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿ÔºÒ©Î↑·¢ÌåϵÏîÄ¿RALF×éÕÐÆ¸¿ÆÑÐÈËÔ±
ÒѾÓÐ0È˻ظ´
Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿Ôº¿¼²©ÕæÌâÇóÖú
ÒѾÓÐ1È˻ظ´
Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿ÔºÒ©Î↑·¢Ìåϵ RALF JAUCH×éÕÐÆ¸¿ÆÑÐÈËÔ±
ÒѾÓÐ2È˻ظ´
Ïë˶ʿ±ÏÒµµÄʱºò½ø¹ãÖÝÊÐÖйú¿ÆÑ§ÔºÉúÎïÒ½ÔºÓ뽡¿µÑо¿Ôº¹¤×÷£¬ÇóÒâ¼ûºÍ½¨Òé
ÒѾÓÐ14È˻ظ´
Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿ÔºÀî־ԶʵÑéÊÒÕÐÆ¸¸±Ñо¿Ô±/ÖúÀíÑо¿Ô±
ÒѾÓÐ1È˻ظ´
Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿ÔºÀî־ԶʵÑéÊÒÕÐÆ¸¸±Ñо¿Ô±/ÖúÀíÑо¿Ô±
ÒѾÓÐ1È˻ظ´
̳×ÓÀïÓÐûÓÐÄÄλºÃÐĵÄͬѧÁ˽âÇñ·¢ÑóÀÏʦ(Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿Ôº)?
ÒѾÓÐ7È˻ظ´
Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿Ôº
ÒѾÓÐ6È˻ظ´
Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿ÔºÕÐÆ¸¸±ÑУ¬ÖúÑÐ
ÒѾÓÐ13È˻ظ´
ÓйØÖйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿Ôº¹¤×÷µÄÒÉÎÊ
ÒѾÓÐ4È˻ظ´
Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿ÔºÕÐÆ¸¸±ÑУ¬ÖúÑÐ
ÒѾÓÐ10È˻ظ´
¡¾½»Á÷¡¿Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿ÔºÑо¿Éú±ÏÒµ´ð±çÒªÇó
ÒѾÓÐ4È˻ظ´
Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿ÔºÑо¿Éú±ÏÒµ´ð±çÒªÇó£¨Óмû¹ý±ÈÕâ¸ö»¹¸ßµÄÂ𣿣©
ÒѾÓÐ46È˻ظ´
¡¾ÇóÖú¡¿Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿Ôº-»¯Ñ§ÉúÎïѧÑо¿ËùÌõ¼þÔõÑù
ÒѾÓÐ0È˻ظ´
ÄäÃû
Óû§×¢Ïú (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 199.6
- É¢½ð: 71
- ºì»¨: 1
- Ìû×Ó: 179
- ÔÚÏß: 52.2Сʱ
- ³æºÅ: 0
- ×¢²á: 2008-10-21
- רҵ: ÉúÎï´ó·Ö×ӽṹÓ빦ÄÜ
4Â¥2014-07-31 04:29:42
aixintian
½ð³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 159.8
- É¢½ð: 634
- ºì»¨: 7
- Ìû×Ó: 1848
- ÔÚÏß: 363.3Сʱ
- ³æºÅ: 892797
- ×¢²á: 2009-11-03
- ÐÔ±ð: GG
- רҵ: Ò©ÎïÉè¼ÆÓëÒ©ÎïÐÅÏ¢

2Â¥2014-07-21 09:40:37
ɹɹÂܲ·Ó§×Ó
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 10
- Ìû×Ó: 5
- ÔÚÏß: 8.7Сʱ
- ³æºÅ: 3270192
- ×¢²á: 2014-06-12
- רҵ: ¶¯ÂöÖàÑùÓ²»¯Ó붯ÂöÓ²»¯
3Â¥2014-07-30 23:46:25













»Ø¸´´ËÂ¥